Category:Graft versus host disease medications

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 19:02, 2 August 2017 by Jwarner (talk | contribs) (Created page with "Medications used to treat the symptoms of graft versus host disease (GVHD). Ibrutinib (Imbruvica) is the only currently ''FDA-approved'' therapy for the treatment of c...")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Medications used to treat the symptoms of graft versus host disease (GVHD).

Subcategories

This category has only the following subcategory.

S

Steroids

Pages in category "Graft versus host disease medications"

The following 9 pages are in this category, out of 9 total.

A

B

Belumosudil (Rezurock)

C

Cyclophosphamide (Cytoxan)

I

Ibrutinib (Imbruvica)

M

Mycophenolate mofetil (CellCept)

R

Ruxolitinib (Jakafi)

V

Vorinostat (Zolinza)

Retrieved from "https://hemonc.org/w/index.php?title=Category:Graft_versus_host_disease_medications&oldid=37753"